Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels

Oncotarget
Ava KwongJames M Ford

Abstract

BRCA1/2 mutations are significant risk factors for hereditary breast and ovarian cancer (HBOC), its mutation frequency in HBOC of Chinese ethnicity is around 9%, in which nearly half are recurrent mutations. In Hong Kong and China, genetic testing and counseling are not as common as in the West. To reduce the barrier of testing, a multiplex SNaPshot genotyping panel that targeted 25 Chinese BRCA1/2 mutation hotspots was developed, and its feasibility was evaluated in a local cohort of 441 breast and 155 ovarian cancer patients. For those who tested negative, they were then subjected to full-gene testing with next-generation sequencing (NGS). BRCA mutation prevalence in this cohort was 8.05% and the yield of the recurrent panel was 3.52%, identifying over 40% of the mutation carriers. Moreover, from 79 Chinese breast cancer cases recruited overseas, 2 recurrent mutations and one novel BRCA2 mutation were detected by the panel and NGS respectively. The developed genotyping panel showed to be an easy-to-perform and more affordable testing tool that can provide important contributions to improve the healthcare of Chinese women with cancer as well as family members that harbor high risk mutations for HBOC.

References

Nov 8, 2001·Journal of the National Cancer Institute·L C HartmannR B Jenkins
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Jul 13, 2006·Journal of Cancer Research and Clinical Oncology·Chuan-Gui SongZhi-Ming Shao
Sep 26, 2006·Oncogene·S M Domchek, B L Weber
Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W KurianJames M Ford
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Oct 27, 2012·Breast Cancer Research and Treatment·Ava KwongEdmond S K Ma
Jan 16, 2013·Journal of Epidemiology·Wenming CaoJi-Cheng Li
Jan 24, 2014·Journal of breast cancer·Haeyoung Kim, Doo Ho Choi
Apr 8, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven J IsakoffLeif W Ellisen
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Apr 30, 2016·Breast Cancer Research and Treatment·Ava KwongSteven A Narod
Aug 27, 2016·Breast Cancer Research and Treatment·Tong LiPatrick C Brennan

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Software Mentioned

Samtools
NNSPLICE
Mutalyzer Name Checker
Mutation Surveyor
ESEF finder
Ensembl Variant Effect Predictor
Genescan Analysis
BWA
MEM
GATK HaplotypeCaller

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

© 2022 Meta ULC. All rights reserved